Skip to main content
The BMJ logoLink to The BMJ
. 2003 Dec 13;327(7428):1379. doi: 10.1136/bmj.327.7428.1379

Prophylactic respiratory physiotherapy after cardiac surgery: systematic review

Patrick Pasquina 1, Martin R Tramèr 2, Bernhard Walder 2
PMCID: PMC292987  PMID: 14670881

Abstract

Objective To assess whether respiratory physiotherapy prevents pulmonary complications after cardiac surgery.

Data sources Searches through Medline, Embase, Cinahl, the Cochrane library, and bibliographies, for randomised trials comparing any type of prophylactic respiratory physiotherapy with another type or no intervention after cardiac surgery, with a follow up of at least two days, and reporting on respiratory outcomes.

Review methods Investigators assessed trial validity independently. Information on study design, population, interventions, and end points was abstracted by one investigator and checked by the others.

Results 18 trials (1457 patients) were identified. Most were of low quality. They tested physical therapy (13 trials), incentive spirometry (eight), continuous positive airway pressure (five), and intermittent positive pressure breathing (three). The maximum follow up was six days. Four trials only had a no intervention control; none showed any significant benefit of physiotherapy. Across all trials and interventions, average values postoperatively were: incidence of atelectasis, 15-98%; incidence of pneumonia, 0-20%; partial pressure of arterial oxygen per inspired oxygen fraction, 212-329 mm Hg; vital capacity, 37-72% of preoperative values; and forced expiratory volume in one second, 34-72%. No intervention showed superiority for any end point. For the most labour intensive intervention, continuous positive airway pressure, the average cost of labour for each patient day was €27 (£19; $32).

Conclusions The usefulness of respiratory physiotherapy for the prevention of pulmonary complications after cardiac surgery remains unproved. Large randomised trials are needed with no intervention controls, clinically relevant end points, and reasonable follow up periods.

Introduction

Pulmonary complications after cardiac surgery prolong hospital stay and increase healthcare costs.1 We performed a systematic review to determine to what extent respiratory physiotherapy prevents such complications, and the best type of physiotherapy intervention.

We chose the setting of cardiac surgery for three reasons. Firstly, patients are prone to pulmonary complications after surgery; up to 65% of patients may have an atelectasis, and 3% may develop pneumonia.2,3 Secondly, the prevalence of cardiac surgery is high; around 110 per 100 000 population annually in the Western world.4 Thirdly, the extra costs of pulmonary complications after cardiac surgery exceed €28 000 (£19 000; $32 000) for each patient.5

Methods

Search strategy

We carried out an extensive search, with no language restrictions, through Medline, Embase, CINAHL, and the Cochrane controlled trials register using these key words: physical therapy, respiratory therapy, breathing exercise, chest physiotherapy, continuous positive airway pressure, incentive spirometry, intermittent positive pressure breathing, noninvasive pressure support ventilation, noninvasive positive pressure ventilation, bilevel positive airway pressure ventilation, cardiac surgery, cardiac operation, coronary artery bypass grafting, and random. The last search was on 19 February 2003. We checked the bibliographies of retrieved reports and reviews.6-8 Not considered were data from abstracts, letters, and animal studies. All main authors of all included studies were contacted.

Inclusion criteria, end points, and definitions

We included full reports of randomised trials of adults or children who had undergone cardiac surgery. Inclusion criteria included any method of prophylactic respiratory physiotherapy compared with no intervention or with another method of respiratory physiotherapy, and an observation period of at least two days.

The trials also had to assess at least one of four end points: atelectasis, pneumonia, oxygenation (partial pressure of arterial oxygen, with the corresponding fractional inspired oxygen), and pulmonary function (vital capacity or forced expiratory volume in one second). If end points were reported at different time points after surgery, we considered the latest. For atelectasis, pneumonia, and adverse effects we extracted dichotomous data. We checked for cointerventions that may have influenced the efficacy of the physiotherapy9: analgesia, respiratory physical therapy other than the tested intervention, and mobilisation. One investigator (PP) abstracted the data, which were independently cross checked by the others. The investigators independently scored the methodological quality of the included studies.10,11

Data analyses

To establish the relative efficacy of physiotherapy in the absence of a gold standard intervention, we regarded as the most valid study design comparisons between an active intervention and a no intervention control. Active (head to head) comparisons were of secondary importance.

We estimated the cost of physiotherapy, assuming that one physiotherapist was treating one patient at a time. The cost for purchase or maintenance of equipment was not considered, but we estimated the cost of labour from reported labour time. If no such data were given, we made three assumptions. Firstly, incentive spirometry comprised 10 inspirations, each session lasting five minutes, and a physiotherapist supervised two sessions a day—a total of 10 minutes for each patient day. Secondly, for continuous and intermittent positive pressure breathing, 10 minutes were needed for installation, 10 minutes for adjustments for each hour of therapy, and five minutes for disconnection—a total of 25 minutes for each patient day. Thirdly, for physical therapy, the physiotherapist needed to be present during the entire treatment period except for breathing exercises, when the same assumptions were made as for incentive spirometry. The average salary of a physiotherapist in Europe was estimated at €13/h (Switzerland €19/h, Belgium €13/h, and France €9/h; data from personal communication in 2003 with physiotherapists working in public hospitals in these countries).

Results

Trial characteristics

Of 107 papers screened, 27 randomised controlled trials were eligible for inclusion; nine were subsequently excluded (figure).12-20 We analysed data from 18 trials (1457 patients) from nine countries, published between 1978 and 2001 (table 1).21-38 Three authors responded to our inquiries23,24,28: all provided supplementary information, which resulted in one additional trial being identified.22 The average group size was 32 patients (range 12-95 patients). Four trials described an adequate randomisation method, two reported on concealment of treatment allocation, and 14 reported on blinding of observers. Three trials used an intention to treat analysis.

Figure 1.

Figure 1

Flow chart of screened, excluded, and analysed papers

Table 1.

Numbers of patients receiving prophylactic physiotherapy by method in included studies (continued on next page)

Study Incentive spirometry Continuous positive airway pressure Physical therapy Intermittent positive pressure breathing Other None
Westerdahl et al 200121 32 36*, 30
De Charmoy and Eales 200022 16 14
Matte et al 200023 30 33 33
Crowe and Bradley 199724 90 95
Johnson et al 199625 41, 34§
Johnson et al 199526 48, 49§
Richter Larsen et al 199527 22 22, 22
Stiller et al 199428 40, 40§ 40
Jousela et al 199429 15 15
Ingwersen et al 199330 17 18, 20
Oikkonen et al 199131 26 26
Pinilla et al 199032 32 26
Jenkins et al 198933 38 35 37
Stock et al 198434 12 13 13
Dull and Dull 198335 17 16 16
Reines et al 198236 25, 19§
Gale and Sanders 198037 52 57
Iverson et al 197838 58 42 45*
*

Blow bottles.

Inspiratory resistance and positive expiratory pressure mask.

Non-invasive ventilatory support with bilevel positive airway pressure.

§

Less intensive physical therapy, more intensive physical therapy.

Positive expiratory pressure mask.

Table 1.

End points and time of evaluation after surgery in included studies (continued from previous page)

End points
Study Atelectasis Pneumonia PaO2/FiO2 Pulmonary function Evaluation (days) postoperatively
Westerdahl et al 200121 Yes Yes 4
De Charmoy and Eales 200022 Yes* Yes Yes 4
Matte et al 200023 Yes Yes Yes Yes 2
Crowe and Bradley 199724 Yes Yes Yes 4
Johnson et al 199625 Yes Yes Yes 6
Johnson et al 199526 Yes* Yes Yes 6
Richter Larsen et al 199527 Yes Yes Yes 2
Stiller et al 199428 Yes Yes Yes 4
Jousela et al 199429 Yes Yes 2
Ingwersen et al 199330 Yes Yes 3
Oikkonen et al 199131 Yes Yes 3
Pinilla et al 199032 Yes Yes 2
Jenkins et al 198933 Yes Yes Yes Yes 4
Stock et al 198434 Yes Yes Yes 4
Dull and Dull 198335 Yes 3
Reines et al 198236 Yes Yes 3
Gale and Sanders 198037 Yes Yes 3
Iverson et al 197838 Yes Yes 3

PaO2=arterial oxygen partial pressure; FiO2=fractional inspired oxygen.

*

Not reported in dichotomous form.

Thirteen trials tested 11 different physical therapy regimens; incentive spirometry (n = 8), continuous positive airway pressure (n = 5), intermittent positive pressure breathing (n = 3), and blow bottles (n = 2). Cointerventions were used in most trials but adequately described in only four. One trial studied children, one trial studied children and adults, and 16 trials studied adults. Average length of stay in the intensive care unit was 2 to 2.8 days and in the hospital was 7.5 to 13 days.

Active intervention versus no intervention control

Four trials had a no intervention control.22,28,33,35 They tested three physical therapy regimens; deep breathing, deep breathing and cough, and deep breathing and costal expansion exercises. Two also tested incentive spirometry.33,35 We found no evidence of superiority of any active intervention for the end points.

Head to head comparisons

Atelectasis

Overall, 14 trials (1266 patients) reported on the incidence of atelectasis (table 2). One study (44 children) found a significantly lower incidence when less intensive physical therapy was compared with more intensive physical therapy.36

Table 2.

Incidence (percentage) of atelectasis and pneumonia in included studies

Prophylactic physiotherapy
Study Incentive spirometry Continuous positive airway pressure Physical therapy Intermittent positive pressure breathing Other None
Atelectasis:
Westerdahl et al 200121 59 69*, 57
Matte et al 200023 30 15 15
Crowe and Bradley 199724 33 23
Johnson et al 199625 34, 35§
Richter Larsen et al 199527 93 95, 90
Stiller et al 199428 98, 94§ 92
Jousela et al 199429 53 47
Oikkonen et al 199131 52 43
Pinilla et al 199032 94 81
Jenkins et al 198933 61 53 65
Stock et al 198434 92 67 92
Reines et al 198236 32, 68§**
Gale and Sanders 198037 65 70
Iverson et al 197838 60 55 40*
Pneumonia:
De Charmoy and Eales 200022 0 0
Matte et al 200023 3 3 0
Crowe and Bradley 199724 9 11
Johnson et al 199625 5, 6§
Johnson et al 199526 17, 20§
Stiller et al 199428 10, 3§ 3
Jenkins et al 198933 5 11 14
Reines et al 198236 8, 5§
Iverson et al 197838 0 2 0*
*

Blow bottles.

Inspiratory resistance and positive expiratory pressure mask.

Non-invasive ventilatory support with bilevel positive airway pressure.

§

Less intensive physical therapy, more intensive physical therapy.

Positive expiratory pressure mask.

**

Statistically significant differences between types of physiotherapy, as reported in original trials.

Pneumonia

Nine trials (942 patients) reported on the incidence of pneumonia (table 2). No statistically significant differences were evident.

Oxygenation

Ten trials (752 patients) reported on partial pressure of arterial oxygen per inspired oxygen fraction (table 3). One trial (58 patients) found a significant increase with continuous positive airway pressure compared with physical therapy.32

Table 3.

Postoperative partial pressure of oxygen and fractional inspired oxygen (PaO2/FiO2), vital capacity, and forced expiratory volume in one second in included studies. Values are means (standard deviations) unless stated otherwise

Prophylactic physiotherapy
Study Incentive spirometry Continuous positive airway pressure Physical therapy Intermittent positive pressure breathing Other None
PaO2/FiO2 (mm Hg):
De Charmoy and Eales 2000 22 287 (67) 281 (44)
Matte et al 2000 23 300 (43) 314 (43) 329 (57)*
Richter Larsen et al 1995 27 305 289, 291§
Stiller et al 1994 28 298 (35), 298 (38) 307 (42)
Jousela et al 1994 29 270 (39) 287 (37)
Ingwersen et al 1993 30 314 317, 325§
Pinilla et al 1990 32 234 (57)** 212 (56)**
Jenkins et al 1989 33 305 (38) 310 (43) 300 (43)
Stock et al 1984 34 233 (43) 235 (42) 248 (53)
Gale and Sanders 1980 37 289 (65) 283 (57)
Vital capacity (ml):
Westerdahl et al 2001 21 2400 (500) 2600 (600)††, 2600 (600)§
Matte et al 2000 23 1332 (398)** 1670 (670)** 1759 (522)***
Crowe and Bradley 1997 24 1547 1372
Johnson et al 1996 25 2100 (1000), 1700 (500)
Johnson et al 1995 26 2700 (700), 2800 (500)
Richter Larsen et al 1995 27 47‡‡ 45‡‡, 41§‡‡
Ingwersen et al 1993 30 45‡‡ 38‡‡, 42§‡‡
Oikkonen et al 1991 31 1441 (114) 1713 (170)
Jenkins et al 1989 33 2200 (600) 2100 (600) 2200 (600)
Stock et al 1984 34 1812 (142) 1409 (154) 1444 (171)
Dull and Dull 1983 35 1980 (510) 1700 (350) 2045 (790)
Forced expiratory volume in one second (ml):
Westerdahl et al 2001 21 1800 (400) 1900 (400)††, 1900 (400)§
Matte et al 2000 23 884 (258)** 1067 (256)** 1097 (369)***
Crowe and Bradley 1997 24 1045 (270) 990 (270)
Johnson et al 1996 25 1600 (800), 1300 (400)
Johnson et al 1995 26 1800 (500), 1700 (500)
Jenkins et al 1989 33 1700 (450) 1700 (350) 1700 (450)
Stock et al 1984 34 1497 (99) 1138 (135) 1197 (152)
Dull and Dull 1983 35 1480 (435) 1320 (320) 1430 (520)
*

Non-invasive ventilatory support with bilevel positive airway pressure.

Standard deviation not available.

Positive expiratory pressure mask.

§

Inspiratory resistance and positive expiratory pressure mask.

Less intensive physical therapy, more intensive physical therapy.

**

Statistically significant differences between interventions, as reported in original trials.

††

Blow bottles.

‡‡

Vital capacity presented as percentage of preoperative volume.

Table 3.

Methodological quality of included studies

Quality assessment of trials
Cointerventions
Study Randomisation* Concealment of allocation Blinding Follow up§ Analgesia Additional physical therapy Mobilisation
Westerdahl et al 200121 1 1 1 1 1 1
De Charmoy and Eales 200022 1 0 1 1 1
Matte et al 200023 1 0 1 1 1 1 0
Crowe and Bradley 199724 2 0 1 1 1 1
Johnson et al 199625 1 0 1 2 2 2
Johnson et al 199526 1 0 1 2 2 1
Richter Larsen et al 199527 1 0 1 1 1 1
Stiller et al 199428 2 0 1 1 1
Jousela et al 199429 1 1 0 0 0 0
Ingwersen et al 199330 1 0 1 1 1 0
Oikkonen et al 199131 1 0 1 1 2
Pinilla et al 199032 2 0 1 1 0 0
Jenkins et al 198933 1 0 1 1 0 2
Stock et al 198434 2 0 1 0 1
Dull and Dull 198335 1 0 0 2 1 1
Reines et al 198236 1 0 1 1
Gale and Sanders 198037 1 0 0 0 1
Iverson et al 197838 0** 0 0 0 1
*

0=none or pseudorandomisation; 1=yes, not specified; 2=yes, and adequate.

0=none; 1=yes.

Results for observer only as scores for patient or provider of intervention were zero for trials.

§

0=none reported; 1 reported; data not analysed according to intention to treat; 2; reported; data analysed according to intention to treat.

0=Not specified; 1=not controlled; 2=controlled.

**

According to patient's hospital number.

Pulmonary function

Overall, 11 trials (921 patients) reported on vital capacity and eight trials (748 patients) reported on forced expiratory volume in one second (table 3). One trial (96 patients) found a significant increase in both with both continuous positive airway pressure and non-invasive ventilation compared with incentive spirometry.23

Adverse effects

Four trials provided dichotomous data on adverse effects; gastric distension in 2-10% of patients and nausea in 0-12% of patients.25,29,32,38 Inconvenience of the mask was reported in 43% of patients receiving continuous positive airway pressure.29,32 During physical therapy, 4% of patients had a percutaneous capillary oxygen saturation of less than 90% and 1% of patients had tachycardia.25 Eleven trials did not mention any adverse effects, and none were observed in two trials.24,28

Cost estimation

The median time patients spent receiving physiotherapy was 80 minutes (range 20-120 minutes) for incentive spirometry, 480 minutes (70 to 720 minutes) for continuous positive airway pressure, 80 minutes (80 to 120 minutes) for intermittent positive pressure breathing, and 120 minutes (data from one trial only) for physical therapy.23,29-32,34,37,38 Physiotherapy lasted on average 0.3 to 5 days.21,22,28,29,31-34,37 The average daily cost of labour for each patient was €6 for incentive spirometry, €10 for physical therapy, €20 for intermittent positive pressure breathing, and €27 for continuous positive airway pressure (table 4).

Table 4.

Estimated time and costs of labour for physiotherapists using different methods of prophylactic respiratory physiotherapy in patients after cardiac surgery

Prophylactic physiotherapy
Incentive spirometry Continuous positive airway pressure Physical therapy Intermittent positive pressure breathing
Median of average labour time per patient and per day (min)* 30 120 45 90
Estimated average labour cost per patient and per day (Euros)* 6 27 10 20
*

Estimation, using assumptions as reported in methods section.

Discussion

Evidence is lacking as to whether prophylactic respiratory physiotherapy prevents pulmonary complications after cardiac surgery. Two published systematic reviews examined the relation between respiratory physiotherapy and outcome after different operations, but they obtained conflicting results. One found benefits from incentive spirometry and deep breathing exercises after upper abdominal surgery, but pooled data came from different end points such as atelectasis and pulmonary infiltrates or consolidation.39 The other review found incentive spirometry to be of no benefit after cardiac and upper abdominal surgery.8 Again, data were combined from trials with a variety of different end points. Our conclusions reflect more uncertainty, showing several limitations in the original trials. These limitations are the main weakness of our systematic review.

Limitations

Eighteen trials tested eight regimens of prophylactic respiratory physiotherapy. This variety, which is not dissimilar to other settings, may be due to the lack of a gold standard method for respiratory physiotherapy.40 If ethically acceptable, the best comparator is then a placebo or, as in the physiotherapy setting, a no intervention control.41 Four trials only had a no intervention control group, and each tested a different method of physiotherapy.22,28,33,35 Based on these trials, it was therefore difficult for us to determine the efficacy of different methods of respiratory physiotherapy.

On average the quality of the trials was low. Only a minority reported on an appropriate method of randomisation or on concealment of allocation, although bad reporting may not mean bad practice. In only a few trials was the follow up of patients adequately reported and data analysed according to intention to treat. One inherent problem of trials in this setting is that at best the observer can be blinded. Over two thirds of the trials attempted to blind the observers. We do not know if trials of better quality would have reached different conclusions.

Practical management of physiotherapy was inconsistent. For example, the reported duration of daily continuous positive airway pressure varied by a factor of 10. Inconsistency suggests that there is uncertainty about how each method should be applied and how frequently.

For most end points there was variability in event rates. The average incidence of pneumonia was 0-20%.22,23,26,38 Two reasons may explain this variability. Firstly, there were no uniform definitions of pneumonia; one study used established criteria only.26 Secondly, most trials were of limited size. Only two studies included groups of more than 50 patients.24,37 In small trials anything can happen by random chance.42

The longest observation period was six days. This may be too short in which to identify all respiratory complications. Nosocomial pneumonia, for instance, occurs on average eight days after cardiac surgery.43

In large randomised controlled trials, cointerventions are usually balanced between the groups. In small trials, however, we cannot exclude bias related to an imbalance of cointerventions. Sixteen of the 18 trials had less than 50 patients in each group, thus cointerventions may have affected the efficacy of physiotherapy. Method and intensity of postoperative analgesia may have an impact on pulmonary function.44 Early mobilisation may also have an effect on outcome. Only three trials adequately controlled for concomitant analgesia or mobilisation.25,26,33

Implications

Because there was no evidence of any benefit from respiratory physiotherapy, we were unable to determine the cost incurred to generate one patient who would profit from an intervention compared with doing nothing. If there is no benefit, there are only costs, and these are not negligible in this context.

What is already known on this topic

Prophylactic respiratory physiotherapy after cardiac surgery is widely used

It is thought to reduce the risk of pulmonary complications such as pneumonia or atelectasis

What this study adds

Evidence is lacking on benefit from any method of prophylactic respiratory physiotherapy after cardiac surgery

It is likely that there are adverse effects and costs only

We thank Daniel Haake (medical libraries, Centre Medical Universitaire, Geneva University) for his help in searching electronic databases, and Kathy Stiller, Jean Crowe, and Pascal Matte who provided additional information.

Contributors: PP initiated, designed, and organised the study, and extracted and analysed the data. He will act as guarantor for the paper. MRT designed the study, cross checked the studies, and analysed the data. BW initiated and designed the study, cross checked the studies, and analysed the data.

Funding: MRT is a beneficiary of a PROSPER grant from the Swiss National Science Foundation (No 3233-051939.97/2).

Competing interests: None declared.

Ethical approval: None required.

References

  • 1.Lawrence VA, Hilsenbeck SG, Mulrow CD, Dhanda R, Sapp J, Page CP. Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery. J Gen Intern Med 1995;10: 671-8. [DOI] [PubMed] [Google Scholar]
  • 2.Jain U, Rao TL, Kumar P, Kleinman BS, Belusko RJ, Kanuri DP, et al. Radiographic pulmonary abnormalities after different types of cardiac surgery. J Cardiothorac Vasc Anesth 1991;5: 592-5. [DOI] [PubMed] [Google Scholar]
  • 3.Carrel TP, Eisinger E, Vogt M, Turina MI. Pneumonia after cardiac surgery is predictable by tracheal aspirates but cannot be prevented by prolonged antibiotic prophylaxis. Ann Thorac Surg 2001;72: 143-8. [DOI] [PubMed] [Google Scholar]
  • 4.Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990;72: 153-84. [DOI] [PubMed] [Google Scholar]
  • 5.Taylor GJ, Mikell FL, Moses HW, Dove JT, Katholi RE, Malik SA, et al. Determinants of hospital charges for coronary artery bypass surgery: the economic consequences of postoperative complications. Am J Cardiol 1990;65: 309-13. [DOI] [PubMed] [Google Scholar]
  • 6.Thornlow DK. Is chest physiotherapy necessary after cardiac surgery? Crit Care Nurse 1995;47: 39-46. [PubMed] [Google Scholar]
  • 7.Denehy L, Berney S. The use of positive pressure devices by physiotherapists. Eur Respir J 2001;17: 821-9. [DOI] [PubMed] [Google Scholar]
  • 8.Overend TJ, Anderson CM, Lucy SD, Bhatia C, Jonsson BI, Timmermans C. The effect of incentive spirometry on postoperative pulmonary complications: a systematic review. Chest 2001;120: 971-8. [DOI] [PubMed] [Google Scholar]
  • 9.Boldt J, Thaler E, Lehmann A, Papsdorf M, Isgro F. Pain management in cardiac surgery patients: comparison between standard therapy and patient-controlled analgesia regimen. J Cardiothorac Vasc Anesth 1998;12: 654-8. [DOI] [PubMed] [Google Scholar]
  • 10.Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999;282: 1054-60. [DOI] [PubMed] [Google Scholar]
  • 11.Juni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001;323: 42-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ruoff M, Koch M, Buhler A, Lindner KH, Brinkmann A, Radermacher P, et al. Effects of CPAP-application via nasal mask and mouth-piece on gas exchange and respiratory mechanics after cardiac surgery. Clin Intensive Care 2000;11: 29-34. [Google Scholar]
  • 13.Oulton JL, Hobbs GM, Hicken P. Incentive breathing devices and chest physiopathy: a controlled therapy. Can J Surg 1981;24: 638-40. [PubMed] [Google Scholar]
  • 14.Vraciu JK, Vraciu RA. Effectiveness of breathing exercises in preventing pulmonary complications following open heart surgery. Phys Ther 1977;57: 1367-71. [DOI] [PubMed] [Google Scholar]
  • 15.Thomas AN, Ryan JP, Doran BR, Pollard BJ. Nasal CPAP after coronary artery surgery. Anaesthesia 1992;47: 316-9. [DOI] [PubMed] [Google Scholar]
  • 16.Krastins I, Corey ML, McLeod A, Edmonds J, Levison H, Moes F. An evaluation of incentive spirometry in the management of pulmonary complications after cardiac surgery in a pediatric population. Crit Care Med 1982;10: 525-8. [DOI] [PubMed] [Google Scholar]
  • 17.Jenkins SC, Soutar SA, Loukota JM, Johnson LC, Moxham J. A comparison of breathing exercises, incentive spirometry and mobilisation after coronary artery surgery. Physiother Theory Pract 1990;6: 117-26. [Google Scholar]
  • 18.Larsen KR, Ingwersen U, Bertelsen MT, Kiil-Nielsen K, Laub MS, Bach KS, et al. Prevention of postoperative pulmonary complications after heart-lung surgery. Comparison of 3 different mask physiotherapy regimens. Ugeskr Laeger 1994;156: 5689-92. [PubMed] [Google Scholar]
  • 19.Stiller K, Montarello J, Wallace M, Daff M, Grant R, et al. Are breathing and coughing exercises necessary after coronary artery surgery? Physiother Theory Pract 1994;10: 143-52. [DOI] [PubMed] [Google Scholar]
  • 20.Larsen KR, Ingwersen U, Thode S, Jakobsen SH. Mask physiotherapy for prevention of pulmonary complications after heart surgery. A controlled study. Ugeskr Laeger 1997;159: 2096-9. [PubMed] [Google Scholar]
  • 21.Westerdahl E, Lindmark B, Almgren SO, Tenling A. Chest physiotherapy after coronary artery bypass graft surgery—a comparison of three different deep breathing techniques. J Rehabil Med 2001;33: 79-84. [DOI] [PubMed] [Google Scholar]
  • 22.De Charmoy SB, Eales CJ. The role of prophylactic chest physiotherpy after cardiac valvular surgery: is there one? S Afr J Physiother 2000;56: 24-8. [Google Scholar]
  • 23.Matte P, Jacquet L, Van Dyck M, Goenen M. Effects of conventional physiotherapy, continuous positive airway pressure and non-invasive ventilatory support with bilevel positive airway pressure after coronary artery bypass grafting. Acta Anaesthesiol Scand 2000;44: 75-81. [DOI] [PubMed] [Google Scholar]
  • 24.Crowe JM, Bradley CA. The effectiveness of incentive spirometry with physical therapy for high-risk patients after coronary artery bypass surgery. Phys Ther 1997;77: 260-8. [DOI] [PubMed] [Google Scholar]
  • 25.Johnson D, Kelm C, Thomson D, Burbridge B, Mayers I. The effect of physical therapy on respiratory complications following cardiac valve surgery. Chest 1996;109: 638-44. [DOI] [PubMed] [Google Scholar]
  • 26.Johnson D, Kelm C, To T, Hurst T, Naik C, Gulka I, et al. Postoperative physical therapy after coronary artery bypass surgery. Am J Respir Crit Care Med 1995;152: 953-8. [DOI] [PubMed] [Google Scholar]
  • 27.Richter Larsen K, Ingwersen U, Thode S, Jakobsen S. Mask physiotherapy in patients after heart surgery: a controlled study. Intensive Care Med 1995;21: 469-74. [DOI] [PubMed] [Google Scholar]
  • 28.Stiller K, Montarello J, Wallace M, Daff M, Grant R, Jenkins S, et al. Efficacy of breathing and coughing exercises in the prevention of pulmonary complications after coronary artery surgery. Chest 1994;105: 741-7. [DOI] [PubMed] [Google Scholar]
  • 29.Jousela I, Rasanen J, Verkkala K, Lamminen A, Makelainen A, Nikki P. Continuous positive airway pressure by mask in patients after coronary surgery. Acta Anaesthesiol Scand 1994;38: 311-6. [DOI] [PubMed] [Google Scholar]
  • 30.Ingwersen UM, Larsen KR, Bertelsen MT, Kiil-Nielsen K, Laub M, Sandermann J, et al. Three different mask physiotherapy regimens for prevention of post-operative pulmonary complications after heart and pulmonary surgery. Intensive Care Med 1993;19: 294-8. [DOI] [PubMed] [Google Scholar]
  • 31.Oikkonen M, Karjalainen K, Kahara V, Kuosa R, Schavikin L. Comparison of incentive spirometry and intermittent positive pressure breathing after coronary artery bypass graft. Chest 1991;99: 60-5. [DOI] [PubMed] [Google Scholar]
  • 32.Pinilla JC, Oleniuk FH, Tan L, Rebeyka I, Tanna N, Wilkinson A, et al. Use of a nasal continuous positive airway pressure mask in the treatment of postoperative atelectasis in aortocoronary bypass surgery. Crit Care Med 1990;18: 836-40. [DOI] [PubMed] [Google Scholar]
  • 33.Jenkins SC, Soutar SA, Loukota JM, Johnson LC, Moxham J. Physiotherapy after coronary artery surgery: are breathing exercises necessary? Thorax 1989;44: 634-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Stock MC, Downs JB, Cooper RB, Lebenson IM, Cleveland J, Weaver DE, et al. Comparison of continuous positive airway pressure, incentive spirometry, and conservative therapy after cardiac operations. Crit Care Med 1984;12: 969-72. [DOI] [PubMed] [Google Scholar]
  • 35.Dull JL, Dull WL. Are maximal inspiratory breathing exercises or incentive spirometry better than early mobilization after cardiopulmonary bypass? Phys Ther 1983;63: 655-9. [DOI] [PubMed] [Google Scholar]
  • 36.Reines HD, Sade RM, Bradford BF, Marshall J. Chest physiotherapy fails to prevent postoperative atelectasis in children after cardiac surgery. Ann Surg 1982;195: 451-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Gale GD, Sanders DE. Incentive spirometry: its value after cardiac surgery. Can Anaesth Soc J 1980;27: 475-80. [DOI] [PubMed] [Google Scholar]
  • 38.Iverson LI, Ecker RR, Fox HE, May IA. A comparative study of IPPB, the incentive spirometer, and blow bottles: the prevention of atelectasis following cardiac surgery. Ann Thorac Surg 1978;25: 197-200. [DOI] [PubMed] [Google Scholar]
  • 39.Thomas JA, McIntosh JM. Are incentive spirometry, intermittent positive pressure breathing, and deep breathing exercises effective in the prevention of postoperative pulmonary complications after upper abdominal surgery? A systematic overview and meta-analysis. Phys Ther 1994;74: 3-10. [DOI] [PubMed] [Google Scholar]
  • 40.Tramèr MR, Reynolds DJ, Moore RA, McQuay HJ. When placebo controlled trials are essential and equivalence trials are inadequate. BMJ 1998;317: 875-80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Temple R, Ellenberg SS. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues. Ann Intern Med 2000;133: 455-63. [DOI] [PubMed] [Google Scholar]
  • 42.Moore RA, Gavaghan D, Tramèr MR, Collins SL, McQuay HJ. Size is everything—large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998;78: 209-16. [DOI] [PubMed] [Google Scholar]
  • 43.Leal-Noval SR, Marquez-Vacaro JA, Garcia-Curiel A, Camacho-Larana P, Rincon-Ferrari MD, Ordonez-Fernandez A, et al. Nosocomial pneumonia in patients undergoing heart surgery. Crit Care Med 2000;28: 935-40. [DOI] [PubMed] [Google Scholar]
  • 44.Hedderich R, Ness TJ. Analgesia for trauma and burns. Crit Care Clin 1999;15: 167-84. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES